Dexlansoprazole

Warning

Contraindicated in patients with known hypersensitivity to any component of the formulation and patients receiving rilpivirine-containing products

Contraindications

• Patients with known hypersensitivity to any component of the formulation
• Patients receiving rilpivirine-containing products

Adverse Reactions

• Diarrhea
• Abdominal pain
• Nausea
• Vomiting

General Guidance

Dose adjustment is recommended for patients with moderate hepatic impairment

Pregnancy

• There are no studies with dexlansoprazole use in pregnant women to inform a drug-associated risk

Nursing Mothers

• No data available

Pediatric Use

• Approved for use in pediatric patients 12-17 years old
• Not recommended for use in pediatric patients less than 2 years old

Geriatric Use

• No overall differences in safety or effectiveness were observed between geriatric and younger patients